Literature DB >> 2419046

A molecular basis for bleomycin-induced pulmonary fibrosis.

K R Cutroneo, K M Sterling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2419046     DOI： 10.1378/chest.89.3_supplement.121s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  3 in total

1.  Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis.

Authors:  Craig E Daniels; Mark C Wilkes; Maryanne Edens; Ted J Kottom; Stephen J Murphy; Andrew H Limper; Edward B Leof
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

2.  Effect of nilotinib on bleomycin-induced acute lung injury and pulmonary fibrosis in mice.

Authors:  Chin Kook Rhee; Sang Haak Lee; Hyung Kyu Yoon; Seok Chan Kim; Sook Young Lee; Soon Suk Kwon; Young Kyoon Kim; Kwan Hyoung Kim; Tae Jung Kim; Jin Woo Kim
Journal:  Respiration       Date:  2011-06-09       Impact factor: 3.580

3.  Chemical Composition of Pinus roxburghii Bark Volatile Oil and Validation of Its Anti-Inflammatory Activity Using Molecular Modelling and Bleomycin-Induced Inflammation in Albino Mice.

Authors:  Rola M Labib; Fadia S Youssef; Mohamed L Ashour; Mohamed M Abdel-Daim; Samir A Ross
Journal:  Molecules       Date:  2017-08-29       Impact factor: 4.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.